| Date Filed | Type | Description |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Bought 23,000 shares
@ $0.71, valued at
$16.3k
Bought 8,000 shares
@ $0.72, valued at
$5.8k
|
|
| 06/03/2021 |
4
| Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Bought 100 options to buy
@ $4.98, valued at
$498
Bought 16,900 options to buy
@ $4.98, valued at
$84.2k
|
|
| 06/01/2021 |
4
| Barrage Khalil (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Granted 180,000 options to buy
@ $0 |
|
| 06/01/2021 |
4
| Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Bought 3,000 options to buy
@ $4.98, valued at
$14.9k
|
|
| 05/20/2021 |
4
| Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Bought 12,000 options to buy
@ $4.98, valued at
$59.8k
Bought 18,000 options to buy
@ $4.98, valued at
$89.6k
|
|
| 05/05/2021 |
4
| Barrage Khalil (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Exercised 45,000 options to buy
@ $1.25, valued at
$56.3k
Exercised 150,000 options to buy
@ $1.25, valued at
$187.5k
Exercised 45,000 options to buy
@ $1.75, valued at
$78.8k
Exercised 120,000 options to buy
@ $1.75, valued at
$210k
|
|
| 05/03/2021 |
4
| Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Bought 1,000 shares
@ $2.29, valued at
$2.3k
Bought 1,000 shares
@ $2.29, valued at
$2.3k
|
|
| 07/21/2020 |
4
| Buell Jennifer (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Granted 145,000 options to buy
@ $1.75, valued at
$253.8k
|
|
| 07/21/2020 |
4
| Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Granted 124,998 options to buy
@ $1.75, valued at
$218.7k
|
|
| 02/26/2020 |
4
| Stein Robert Benjamin (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Granted 150,000 options to buy
@ $1.75, valued at
$262.5k
|
|
| 02/26/2020 |
4
| Barrage Khalil (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Granted 120,000 options to buy
@ $1.75, valued at
$210k
|
|
| 02/26/2020 |
4
| Silverman Joshua (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Granted 120,000 options to buy
@ $1.75, valued at
$210k
|
|
| 02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2020 |
4
| Corvese Brian (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Granted 120,000 options to buy
@ $1.75, valued at
$210k
|
|
| 02/26/2020 |
4
| Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Granted 307,497 options to buy
@ $1.75, valued at
$538.1k
|
|
| 03/25/2019 |
4
| Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Granted 41,667 options to buy
@ $1, valued at
$41.7k
|
|
| 10/18/2017 |
4
| Corvese Brian (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Granted 95,000 options to buy
@ $1.75, valued at
$166.3k
|
|
| 10/18/2017 |
4
| Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Granted 75,000 options to buy
@ $1.75, valued at
$131.3k
|
|
| 10/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2017 |
4
| Stein Robert Benjamin (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Granted 200,000 options to buy
@ $1.75, valued at
$350k
|
|
| 10/18/2017 |
4
| Silverman Joshua (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Granted 45,000 options to buy
@ $1.75, valued at
$78.8k
|
|
| 10/18/2017 |
4
| Barrage Khalil (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Granted 45,000 options to buy
@ $1.75, valued at
$78.8k
|
|
| 08/18/2016 |
4
| ARMEN GARO H (See Remarks) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Bought 60,211 shares
@ $1.25, valued at
$75.3k
|
|
| 08/10/2016 |
4
| Barrage Khalil (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new |
| 06/22/2016 |
4
| Ekizian Gregory (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Granted 45,000 shares
@ $1.25, valued at
$56.3k
|
|
| 06/21/2016 |
4
| Arrow Alexander K. (CFO) has filed a Form 4 on Protagenic Therapeutics, Inc.\new|
Txns:
| Granted 140,000 shares
@ $1.25, valued at
$175k
|
|
| 06/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/21/2016 |
4
| Silverman Joshua (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new |
| 06/21/2016 |
4
| Barrage Khalil (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new |
| 06/21/2016 |
4
| Stein Robert Benjamin (Director) has filed a Form 4 on Protagenic Therapeutics, Inc.\new |
| 05/10/2016 |
4
| Arrow Alexander K. (CFO) has filed a Form 4 on Atrinsic, Inc.|
Txns:
| Bought 40,000 preferred shares
@ $1.25, valued at
$50k
Bought 18,260 preferred shares
@ $1.25, valued at
$22.8k
|
|
| 03/23/2016 |
3
| Silverman Joshua (Director) has filed a Form 3 on Atrinsic, Inc. |
| 09/20/2011 |
3
| Fong Nathan Yu-Gai (CFO) has filed a Form 3 on Atrinsic, Inc. |
|